Among young adults ages 18 to 24, college students are more than
three times as likely to be infected with meningococcal disease
serogroup B, researchers found. These bacteria can enter the
bloodstream and lead to severe swelling in the brain and spinal
cord. Even though the relatively new MenB vaccine helps protect
against this strain, it isn't widely used or recommended for all
teens or college students, the study team notes in Pediatrics.
"Our results demonstrate that while the incidence of disease is low
in persons aged 18-24 years, college students are at increased risk
for serogroup B meningococcal disease compared to non-college
students," said lead study author Dr. Sarah Mbaeyi of the U.S.
Centers for Disease Control and Prevention (CDC) in Atlanta.
"College students, parents, and providers should be aware of the
availability of MenB vaccines," Mbaeyi said by email.
The disease kills about 10 to 15 percent of people who catch it,
previous research has found. Many survivors have lasting impairments
like neurological deficits, loss of limbs or digits and hearing
loss.
The older MenACWY vaccine covers four other strains of meningococcal
disease and is recommended as a routine childhood vaccination as
well as for any unvaccinated or under-vaccinated college students
living in residence halls, Mbaeyi and her colleagues note.
Due in part to more widespread vaccination, these strains are less
common than strains covered by the MenB vaccine, they write.
For the study, the researchers examined national data on all
meningococcal disease cases among young adults 18 to 24 years old,
including both college students and those not enrolled in school,
over a two-year period.
During this time, there were 166 cases of meningococcal disease
among young adults, for an average annual rate of 0.17 cases for
every 100,000 people in this age group.
[to top of second column] |
Six serogroup B outbreaks were identified on college campuses,
accounting for about one third of the cases of this strain developed
by students during the study period. However, among all meningitis
cases in college students during this period, 77 percent involved
serogroup B. That compares to 38 percent of the meningococcal
disease cases in peers who were not college students.
The study wasn't designed to prove whether or how college students
might be more likely to contract serogroup B strains of
meningococcal disease. In addition, too few students were infected
for researchers to identify trends over time in infection rates
among college students.
Bacterial meningitis may be spread by coughing, sneezing or kissing.
People can carry the bacteria and spread it to others even when they
aren't sick, according to the CDC.
"The infection is transmitted from person to person and requires
close contact," said Dr. Lucila Marquez of Baylor College of
Medicine and Texas Children's Hospital in Houston.
"Therefore, it seems logical that living in dorms or any activity
that could put young adults in close proximity for extended periods
of time could increase the risk of infection," Marquez, coauthor of
an accompanying editorial, said by email.
The higher risk faced by students in the study has the potential to
prompt changes in national vaccine guidelines to recommend routine
MenB vaccination for college attendees, Marquez said.
SOURCE: https://bit.ly/2CKiMWC and https://bit.ly/2s6I1MU
Pediatrics, online December 31, 2018.
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |